title: Is the thrombopoietin assay useful for differential diagnosis of thrombocytopenia? Analysis of a cohort of 160 patients with thrombocytopenia and defined platelet life span.
abstract: BACKGROUND
  Thrombopoietin (TPO), the major hormone controlling platelet production, has been measured in thrombocytopenias with discordant results. The aim of our work was to assess the value of the TPO assay for differential diagnosis of thrombocytopenias in a large cohort of patients classified according to the results of their platelet isotopic study.
  
  
  METHODS
  We measured TPO (R&D Systems) in serum of 160 thrombocytopenic patients referred to our department for platelet life span isotopic studies. We classified patients as follows: (a) idiopathic or autoimmune thrombocytopenia group (ITP; patients with increased platelet destruction and shortened platelet life span; n = 67); (b) pure genetic thrombocytopenia group (patients with decreased platelet production, normal platelet life span, and without bone marrow aplasia; n = 55); (c) bone marrow aplasia group (BM; patients with decreased platelet production, normal platelet life span, and bone marrow aplasia; n = 13).
  
  
  RESULTS
  In patients with pure genetic thrombocytopenia, TPO (median, 55 ng/L) was not different from TPO in patients with ITP (median, 58 ng/L) or controls (n = 54; median, 51 ng/L). Only in patients with bone marrow aplasia was TPO significantly higher (median, 155 ng/L) and negatively correlated to the platelet count (r(2) = 0.5014).
  
  
  CONCLUSIONS
  Although the median serum TPO is increased in thrombocytopenia with decreased platelet production from bone marrow aplasia, it does not differentiate patients with pure genetic thrombocytopenia from those with ITP.
authors.affiliation: Service de Médecine Nucléaire, Hôpital Saint-Louis, Assistance Publique, Hôpitaux de Paris, 1, Avenue Claude Vellefaux, 75475 Paris Cedex 10, France.
authors.forename: I
authors.initials: I
authors.lastname: Gouin-Thibault
authors.forename: B
authors.initials: B
authors.lastname: Cassinat
authors.forename: C
authors.initials: C
authors.lastname: Chomienne
authors.forename: J D
authors.initials: JD
authors.lastname: Rain
authors.forename: Y
authors.initials: Y
authors.lastname: Najean
authors.forename: M H
authors.initials: MH
authors.lastname: Schlageter
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal; D001792:Blood Platelets / Q000473:pathology*; D002648:Child; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007205:Indium Radioisotopes; D008297:Male; D008875:Middle Aged; D013921:Thrombocytopenia / Q000097:blood / Q000175:diagnosis* / Q000209:etiology; D013926:Thrombopoietin / Q000097:blood* / Q000302:isolation & purification
chemical_list: D000911:Antibodies, Monoclonal; D007205:Indium Radioisotopes; D013926:Thrombopoietin